In this issue:
Second-line sulfonylureas in type 2 diabetes: CV/hypoglycaemia risk
Predicted lean body/fat mass and mortality in men
Maternal healthy lifestyle practices and offsprings’ obesity risk
Periconceptional glycaemic control in type 1 diabetes and birth defect risk
Cause-specific mortality trends among diabetics and nondiabetics
Metformin and lactic acidosis risk according to renal function
Adiposity, vascular phenotypes and cognitive function patterns
HbA1c and weight changes after starting second-line therapy for type 2 diabetes
Lifestyle interventions for preventing diabetes
Real-world HbA1c response after initiating insulin for type 2 diabetes
Please login below to download this issue (PDF)